TBG Diagnostics financials at a glance
| Year | Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
2.70M | 3.45M | 3.15M | 3.35M | 4.61M | 0.00M |
| GM % | Gross Margin % |
|
69.83% | 77.58% | 88.53% | 75.41% | 57.69% | 0.00% |
| OM | Operating Margin |
|
-233.19% | -82.80% | -74.18% | -119.80% | -74.31% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | |||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
217.59m | 217.59m | 217.59m | 217.59m | 0m | 217.59m |
| OCF | Operating Cash Flow |
|
-5.55M | -2.43M | -2.73M | -2.32M | -3.39M | 0.00M |
| FCF | Free Cash Flow |
|
-5.77M | -2.86M | -4.20M | -2.59M | -3.52M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-0.03 | -0.01 | -0.02 | -0.01 | -0.02 | 0.00 |